American Society of Clinical Oncology

SHERPA: White

People

  1. Drilon
    Drilon
  2. Kris
    Kris
  3. Arcila
    Arcila
  4. Ladanyi
    Ladanyi
  5. Rudin
    Rudin
  6. Offin
    Offin
  7. Riely
    Riely
  8. Berger
    Berger
  9. Schram
    Schram
  10. Rekhtman
    Rekhtman

Groups

  1. Department of Medicine (163)
  2. Solid Tumor Oncology Division (163)
  3. Thoracic Oncology (163)
  4. Department of Pathology and Laboratory Medicine (63)
  5. Hematology-Oncology Fellows (61)
  6. GSK Faculty (54)
  7. Weinberg Fellows (47)
  8. Human Oncology and Pathogenesis Program (42)
  9. Center for Molecular Imaging and Biotechnology (CMIB) (39)
  10. Early Drug Development Service (32)
Search Within
  1. "Alexander Drilon"
Formats
  1. Meeting Abstract (127)
  2. Journal Article (35)
  3. Correspondence (1)
Groups
  1. Department of Medicine (163)
  2. Solid Tumor Oncology Division (163)
  3. Thoracic Oncology (163)
  4. Department of Pathology and Laboratory Medicine (63)
  5. Hematology-Oncology Fellows (61)
  6. GSK Faculty (54)

More Groups

People
  1. Alexander Drilon (163)
  2. Mark Kris (33)
  3. Marc Ladanyi (30)
  4. Maria Arcila (30)
  5. Bob Li (25)
  6. Charles Rudin (25)

More People

Years
  1. 2025 (2)
  2. 2024 (18)
  3. 2023 (18)
  4. 2022 (22)
  5. 2021 (19)
  6. 2020 (18)

More Years

Publications
  1. Journal of Clinical Oncology (138)
  2. JCO Precision Oncology (24)
  3. American Society of Clinical Oncology Educational Book (1)

Results (163)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Selpercatinib in RET fusion-positive non-small cell lung cancer: Final safety and efficacy, including overall survival, from the LIBRETTO-001 phase I/II trial
    Journal Article

    Gautschi, O.; Park, K.; Solomon, B. J.; Tomasini, P.; Loong, H. H.; De Braud, F.; Goto, K.; Peterson, P.; Barker, S.; Liming, K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Larotrectinib compared with real-world non-tropomyosin receptor kinase inhibitor therapies in patients with tropomyosin receptor kinase fusion cancer
    Journal Article

    Brose, M. S.; Westphalen, C. B.; Pan, X.; Bernard-Gauthier, V.; Kurtinecz, M.; Guo, H.; Aris, V.; Brett, N. R.; Majdi, A.; Subbiah, V.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Durable efficacy of selpercatinib in patients with RET fusion plus solid tumors, with a focus on GI tumors: LIBRETTO-001
    Meeting Abstract

    Subbiah, V.; Drilon, A. E.; Sukrithan, V.; Spira, A. I.; Robinson, B.; Deschler-Baier, B.; Barker, S.; Lin, Y.; Szymczak, S.; Ohe, Y.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • BRAF variants and oncogenic fusions to define sporadic MMR-deficient colorectal cancer subtypes
    Meeting Abstract

    Abdelfattah, S.; Harada, G.; Patel, S.; Artz, O.; Yaeger, R.; Johannet, P.; Harrold, E.; Walch, H. S.; Argiles, G.; Rousseau, B.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Updated efficacy and safety of larotrectinib (laro) in patients (pts) with TRK fusion gastrointestinal (GI) cancer
    Meeting Abstract

    Shen, L.; Andre, T.; Chung, H. C. C.; Deeken, J. F.; Garralda, E.; Italiano, A.; Leyvraz, S.; Liu, T.; Burcoveanu, D. I.; Grugel, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Intratumoral escherichia is associated with improved survival to single-agent immune checkpoint inhibition in patients with advanced non–small-cell lung cancer
    Journal Article

    Elkrief, A.; Montesion, M.; Sivakumar, S.; Hale, C.; Bowman, A. S.; Begüm Bektaş, A.; Bradic, M.; Kang, W.; Chan, E.; Gogia, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Durability of response with selpercatinib in patients with RET -activated thyroid cancer: Long-term safety and efficacy from LIBRETTO-001
    Journal Article

    Wirth, L. J.; Brose, M. S.; Subbiah, V.; Worden, F.; Solomon, B.; Robinson, B.; Hadoux, J.; Tomasini, P.; Weiler, D.; Deschler-Baier, B.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Early circulating tumor DNA shedding kinetics for prediction of platinum sensitivity in patients with small cell lung cancer
    Journal Article

    Murciano-Goroff, Y. R.; Hui, A. B. Y.; Araujo Filho, J. A.; Hamilton, E. G.; Chabon, J. J.; Moding, E. J.; Bonilla, R. F.; Lebow, E. S.; Gomez, D.; Rimner, A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Long-term efficacy and safety of larotrectinib (laro) in patients (pts) with TRK fusion thyroid carcinoma (TC)
    Meeting Abstract

    Cabanillas, M. E.; Lin, J. J.; Brose, M. S.; McDermott, R. S.; Almubarak, M.; Bauman, J. R.; Casanova, M.; Kummar, S.; Lee, S. H.; Leyvraz, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Repotrectinib in tyrosine kinase inhibitor (TKI)-naïve patients (pts) with advanced ROS1 fusion-positive (ROS1+) NSCLC in the phase 1/2 TRIDENT-1 trial: Clinical update, treatment beyond progression and subsequent therapies
    Meeting Abstract

    Drilon, A. E.; Dziadziuszko, R.; Camidge, D. R.; Lin, J. J.; Besse, B.; Kim, S. W.; Lee, K. H.; Solomon, B. J.; Nagasaka, M.; Goto, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save